48 related articles for article (PubMed ID: 10353598)
1. Regulation of mRNA splicing and transport by the tyrosine kinase activity of src.
Gondran P; Dautry F
Oncogene; 1999 Apr; 18(16):2547-55. PubMed ID: 10353598
[TBL] [Abstract][Full Text] [Related]
2. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
Summy JM; Guappone AC; Sudol M; Flynn DC
Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between the catalytic and regulatory domains allows bidirectional regulation of Src.
Gonfloni S; Weijland A; Kretzschmar J; Superti-Furga G
Nat Struct Biol; 2000 Apr; 7(4):281-6. PubMed ID: 10742171
[TBL] [Abstract][Full Text] [Related]
4. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
[TBL] [Abstract][Full Text] [Related]
5. Mutational investigation of the specificity determining region of the Src SH2 domain.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
[TBL] [Abstract][Full Text] [Related]
6. The intrinsic ability of AFAP-110 to alter actin filament integrity is linked with its ability to also activate cellular tyrosine kinases.
Baisden JM; Gatesman AS; Cherezova L; Jiang BH; Flynn DC
Oncogene; 2001 Oct; 20(45):6607-16. PubMed ID: 11641786
[TBL] [Abstract][Full Text] [Related]
7. RACK1: a novel substrate for the Src protein-tyrosine kinase.
Chang BY; Harte RA; Cartwright CA
Oncogene; 2002 Oct; 21(50):7619-29. PubMed ID: 12400005
[TBL] [Abstract][Full Text] [Related]
8. ARAP3 is transiently tyrosine phosphorylated in cells attaching to fibronectin and inhibits cell spreading in a RhoGAP-dependent manner.
I ST; Nie Z; Stewart A; Najdovska M; Hall NE; He H; Randazzo PA; Lock P
J Cell Sci; 2004 Dec; 117(Pt 25):6071-84. PubMed ID: 15546919
[TBL] [Abstract][Full Text] [Related]
9. Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses.
Zisch AH; Pazzagli C; Freeman AL; Schneller M; Hadman M; Smith JW; Ruoslahti E; Pasquale EB
Oncogene; 2000 Jan; 19(2):177-87. PubMed ID: 10644995
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis for regulation of Src by the docking protein p130Cas.
Nasertorabi F; Tars K; Becherer K; Kodandapani R; Liljas L; Vuori K; Ely KR
J Mol Recognit; 2006; 19(1):30-8. PubMed ID: 16245368
[TBL] [Abstract][Full Text] [Related]
11. STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.
Sachsenmaier C; Sadowski HB; Cooper JA
Oncogene; 1999 Jun; 18(24):3583-92. PubMed ID: 10380880
[TBL] [Abstract][Full Text] [Related]
12. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
Brasher BB; Roumiantsev S; Van Etten RA
Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation of caveolin-2 at residue 27: differences in the spatial and temporal behavior of phospho-Cav-2 (pY19 and pY27).
Wang XB; Lee H; Capozza F; Marmon S; Sotgia F; Brooks JW; Campos-Gonzalez R; Lisanti MP
Biochemistry; 2004 Nov; 43(43):13694-706. PubMed ID: 15504032
[TBL] [Abstract][Full Text] [Related]
15. Evidence for SH3 domain directed binding and phosphorylation of Sam68 by Src.
Shen Z; Batzer A; Koehler JA; Polakis P; Schlessinger J; Lydon NB; Moran MF
Oncogene; 1999 Aug; 18(33):4647-53. PubMed ID: 10467411
[TBL] [Abstract][Full Text] [Related]
16. Sam68 associates with the SH3 domains of Grb2 recruiting GAP to the Grb2-SOS complex in insulin receptor signaling.
Najib S; Sánchez-Margalet V
J Cell Biochem; 2002; 86(1):99-106. PubMed ID: 12112020
[TBL] [Abstract][Full Text] [Related]
17. Microexon-based regulation of ITSN1 and Src SH3 domains specificity relies on introduction of charged amino acids into the interaction interface.
Dergai M; Tsyba L; Dergai O; Zlatskii I; Skrypkina I; Kovalenko V; Rynditch A
Biochem Biophys Res Commun; 2010 Aug; 399(2):307-12. PubMed ID: 20659428
[TBL] [Abstract][Full Text] [Related]
18. Regulation of pre-mRNA processing by src.
Neel H; Gondran P; Weil D; Dautry F
Curr Biol; 1995 Apr; 5(4):413-22. PubMed ID: 7627556
[TBL] [Abstract][Full Text] [Related]
19. Recent progress of Src SH2 and SH3 inhibitors as anticancer agents.
Lu XL; Cao X; Liu XY; Jiao BH
Curr Med Chem; 2010; 17(12):1117-24. PubMed ID: 20158477
[TBL] [Abstract][Full Text] [Related]
20. The Src module: an ancient scaffold in the evolution of cytoplasmic tyrosine kinases.
Shah NH; Amacher JF; Nocka LM; Kuriyan J
Crit Rev Biochem Mol Biol; 2018 Oct; 53(5):535-563. PubMed ID: 30183386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]